Journal Guides8 min readUpdated Apr 20, 2026

Cell Stem Cell Review Time

Cell Stem Cell's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.

Research Scientist, Neuroscience & Cell Biology

Author context

Works across neuroscience and cell biology, with direct expertise in preparing manuscripts for PNAS, Nature Neuroscience, Neuron, eLife, and Nature Communications.

What to do next

Already submitted to Cell Stem Cell? Use this page to interpret the status and choose the next step.

The useful next step is understanding what the status usually means at Cell Stem Cell, how long the wait normally runs, and when a follow-up is actually reasonable.

See The Next StepAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness Scan
Timeline context

Cell Stem Cell review timeline: what the data shows

Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.

Full journal profile
Time to decision30-45 daysFirst decision
Acceptance rate~10%Overall selectivity
Impact factor19.8Clarivate JCR

What shapes the timeline

  • Desk decisions are fast. Scope problems surface within days.
  • Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
  • Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.

What to do while waiting

  • Track status in the submission portal — status changes signal active review.
  • Wait at least the journal's stated median before sending a status inquiry.
  • Prepare revision materials in parallel if you expect a revise-and-resubmit decision.

Quick answer: Cell Stem Cell review time looks extremely fast on the first number and much more normal on the full path. The journal's ScienceDirect insights page currently reports 4 days to first decision, 33 days to decision after review, and 170 days from submission to acceptance. That tells you the same story many authors eventually learn the hard way: Cell Stem Cell is very fast at deciding whether the paper belongs in the conversation, and much slower once the manuscript survives and has to prove it deserves the journal's mechanism-and-function standard.

Cell Stem Cell metrics at a glance

Metric
Current value
What it means for authors
Submission to first decision
4 days
Cell Press triage is very fast
Submission to decision after review
33 days
Reviewed files can still move on a disciplined clock
Submission to acceptance
170 days
The real path is much longer than the desk number
Impact Factor (JCR 2024)
20.4
Cell Stem Cell remains the specialized flagship for stem cell biology
CiteScore (2024)
32.9
Citation strength remains very high inside the field
APC (OA option)
$10,400
Open access is optional and expensive
Main fit test
Functional proof plus mechanistic consequence
Descriptive stem cell papers struggle
Editorial model
Cell Press professional editors
Identity and completeness get judged quickly

The useful reading is not "this journal is fast." The useful reading is "this journal is fast at saying no, and selective about what earns a longer process."

What the official numbers do and do not tell you

ScienceDirect gives unusually concrete timing information for Cell Stem Cell.

It tells you:

  • editors usually know quickly whether a submission deserves more time
  • reviewed papers can move efficiently once they are in the system
  • the full acceptance path still includes a meaningful revision burden

It does not tell you:

  • how many papers fail because the story is still descriptive rather than functional
  • how much of the 170-day number comes from major mechanistic revisions
  • how often the real problem is not speed but submitting a beautiful stem cell paper that is not yet a Cell Stem Cell paper

That difference matters because Cell Stem Cell is not just choosing the best-looking data. It is screening for function-first stem cell biology.

A practical timeline authors can actually plan around

Stage
Practical expectation
What is happening
Editorial intake
A few days
Editors decide whether the package already looks Cell Stem Cell-ready
Desk decision
Often close to the 4-day official benchmark
Descriptive or incomplete stories get filtered very early
Reviewer recruitment
Several days to about 1 week
The journal wants reviewers who can judge both mechanism and function
Decision after review
Often close to the 33-day official benchmark
Reviewed papers move with a fairly disciplined process
Revision cycle
Several weeks to months
Functional validation and scope calibration are common demands
Acceptance
Around the 170-day official benchmark
The real author clock includes revision and editorial standards

This is why the journal can feel brutal at the front and still not be a truly short full-cycle venue.

Why Cell Stem Cell often feels fast at the desk

Cell Stem Cell has a very clear editorial identity. Editors often reject quickly when a paper is:

  • strong in single-cell profiling but weaker in function
  • elegant in organoid or iPSC characterization but still thin on biological consequence
  • interesting inside one system but not broad enough for the stem cell field
  • mechanistically suggestive rather than mechanistically demonstrated
  • better suited to Developmental Cell, Cell Reports, Stem Cell Reports, or a tissue-specific journal

That speed is not accidental. It reflects a journal that knows the difference between stem cell data and stem cell argument.

What usually slows Cell Stem Cell down

The slower papers are usually the ones that the journal takes seriously and then tests hard.

The common causes are:

  • reviewer pressure for stronger functional validation
  • disagreements about whether the finding changes broader stem cell thinking
  • requests for cleaner in vivo support or orthogonal evidence
  • revision rounds where descriptive additions do not solve mechanistic doubts
  • manuscripts that are close enough to review but not yet complete enough to finish cleanly

When Cell Stem Cell feels slow, the reason is often that the paper is being asked to become more truly Cell Stem Cell-like.

Cell Stem Cell impact-factor trend and what it means for review time

Year
Impact Factor
2017
23.3
2018
21.5
2019
20.9
2020
24.6
2021
25.3
2022
23.9
2023
19.8
2024
20.4

Cell Stem Cell is up from 19.8 in 2023 to 20.4 in 2024, even though it remains below the 2020 to 2022 spike.

For review time, the main implication is that the journal still has enough demand and prestige to keep its fast triage behavior. It does not need to soften the first screen.

How Cell Stem Cell compares with nearby journals on timing

Journal
Timing signal
Editorial posture
Cell Stem Cell
Very fast triage, moderate full path
Functional stem cell biology with high selectivity
Developmental Cell
Slower and more development-focused
Better if developmental mechanism is the center
Nature Cell Biology
Comparable elite scrutiny with broader cell-biology scope
Better when stem cells are not the only real audience
Cell Reports
More accessible and less function-purist
Better for strong but less complete stories
Stem Cell Reports
Cleaner fit for solid field papers without the same flagship bar
Good when completeness is strong but consequence is narrower

This matters because many authors experiencing "timing problems" at Cell Stem Cell are really experiencing a target problem. The paper can be good and still be one journal too high.

Readiness check

While you wait on Cell Stem Cell, scan your next manuscript.

The scan takes 60 seconds. Use the result to decide whether to revise before the decision comes back.

Check my next manuscriptAnthropic Privacy Partner. Zero-retention manuscript processing.

What review-time data hides

Even good journal insights data hide several things:

  • the 4-day number is mostly a triage number
  • the reviewed-paper path still depends on functional proof
  • the journal is screening for biological consequence, not only technical ambition
  • timing alone cannot rescue a manuscript that is still descriptive

So the numbers help, but the real determinant is whether the evidence package already carries the editorial argument.

In our pre-submission review work with Cell Stem Cell manuscripts

In our pre-submission review work, the biggest timing mistake is assuming that a paper with strong single-cell atlases, organoids, or lineage description should go to Cell Stem Cell first because the desk answer comes back quickly.

The papers that move best here usually have:

  • functional proof visible in the early figures
  • a mechanistic claim that does not depend on reviewer generosity
  • significance that extends beyond one protocol or tissue compartment
  • enough completeness that revision is about sharpening, not rescuing

Those traits make the journal's speed work for the manuscript rather than against it.

Submit if / Think twice if

Submit if the paper already demonstrates function, mechanism, and broader stem cell consequence in a way that feels complete before submission.

Think twice if the manuscript is still mainly descriptive, still leaning on inferred biology, or still one obvious functional experiment short. In those cases, the review-time question is usually not the real bottleneck.

What should drive the submission decision instead

For Cell Stem Cell, timing matters less than functional completeness. The better question is whether the current package already behaves like a function-first stem cell paper.

That is why the better next reads are:

A Cell Stem Cell readiness check is usually more useful than focusing on the 4-day triage number.

Practical verdict

Cell Stem Cell review time is fast where the journal is confident and slower where the science has to earn its place. The front end is extremely quick. The full path is not. If the manuscript truly has function and mechanism already in hand, the process can be efficient. If not, the journal usually tells you quickly, and that is the most useful part of the clock.

Frequently asked questions

Cell Stem Cell's ScienceDirect insights page currently reports 4 days from submission to first decision. That number reflects very fast Cell Press triage and should not be confused with the full reviewed-paper path.

Cell Stem Cell currently reports 33 days from submission to decision after review on its ScienceDirect insights page. That suggests reviewed manuscripts can move in a disciplined way once they clear triage.

Cell Stem Cell currently reports 170 days from submission to acceptance. That is the better planning number for authors because it captures the real revision burden.

Functional proof matters more than speed. If the paper does not already demonstrate what the cells do and why, the main issue is usually readiness and fit, not review tempo.

References

Sources

  1. 1. Cell Stem Cell journal insights, ScienceDirect.
  2. 2. Cell Stem Cell guide for authors, Cell Press.
  3. 3. Cell Stem Cell impact history, BioxBio.
  4. 4. Cell Stem Cell presubmission inquiry, Cell Press.

Reference library

Use the core publishing datasets alongside this guide

This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: whether the package is ready, what drives desk rejection, how journals compare, and what the submission requirements look like across journals.

Open the reference library

Best next step

Use this page to interpret the status and choose the next sensible move.

For Cell Stem Cell, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.

Guidance first. Use the scan for the next manuscript.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Status Guide